Avrobio Inc reported $16.19M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Akebia Therapeutics AKBA:US USD 187.96M 45.72M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Gilead Sciences GILD:US USD 11.24B 814M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Macrogenics MGNX:US USD 50.05M 831K
Roche Holding ROG:VX 27.41B 11.01B
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
Takeda 4502:JP JPY 2.24T 154.91B